Authors: Jennifer Kates (Kaiser Family Foundation), Eric Lief (The Stimson Center), Carlos Avila (UNAIDS).

Similar documents
Key Highlights continued

Authors: Jennifer Kates (Kaiser Family Foundation), José-Antonio Izazola (UNAIDS), Eric Lief (CSIS).

Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2011

Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2010

Donor Government Funding for HIV in Low- and Middle-Income Countries in 2017

Financing the Response to HIV/AIDS in Low and Middle Income Countries: Funding for HIV/AIDS from the G7 and the European Commission

Donor Government Funding for HIV in Low- and Middle-Income Countries in 2016

Financing the Response to HIV/AIDS in Low and Middle Income Countries: Funding for HIV/AIDS from the G7 and the European Commission

INTERNATIONAL ASSISTANCE FOR HIV/AIDS IN THE DEVELOPING WORLD: TAKING STOCK OF

Financial Resources for HIV: PEPFAR s Contributions to the Global Scale-up of Treatment

Global Funding for HIV/AIDS in Resource Poor Settings

Overview of development assistance for health trends

Monitoring the Declaration of Commitment on HIV/AIDS & UNGASS indicators

Post-2015: Innovative Financing of HIV/AIDS. Travis Mitchell Economic Affairs Division

Overview of development assistance for health trends

CRS Report for Congress

Okinawa, Toyako, and Beyond: Progress on Health and Development

RESOURCE NEEDS FOR AN EXPANDED RESPONSE TO AIDS IN LOW AND MIDDLE INCOME COUNTRIES. Presented at the Programme Coordinating Board

Innovative Finance: the power of innovation to save lives

DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION

39th Meeting of the UNAIDS Programme Coordinating Board Geneva, Switzerland. 6-8 December 2016

The U.S. President s Emergency Plan for AIDS Relief (PEPFAR)

Request for Letters of Intent. International Development of H5N1 Influenza Vaccines

This brief analyses investments by OECD Development Assistance Committee (DAC) donors in six policy areas

Reflecting on ten years of progress in the fight against AIDS, TB and malaria

In 2013, around 12.9 million people living with HIV had access to antiretroviral therapy.

1. The World Bank-GAVI Partnership and the Purpose of the Review

GLOBAL INVESTMENT IN HIV CURE RESEARCH AND DEVELOPMENT IN 2017 AFTER YEARS OF RAPID GROWTH FUNDING INCREASES SLOW

OUTLOOK EXAMINES MAKING SENSE OF THE MONEY + WHERE DOES THE MONEY FOR AIDS GO?

Development assistance for HIV/AIDS, tuberculosis and malaria by channel

The power of innovation to save lives

Tuberculosis-related deaths in people living with HIV have fallen by 36% since 2004.

Uniting the world against AIDS

IMPACT OF DEVELOPMENT ASSISTANCE FOR HEALTH ON COUNTRY SPENDING

Filling the Funding Gap to Save Lives

Drug Money: the illicit proceeds of opiates trafficked on the Balkan route. Executive summary

GLOBAL STATISTICS FACT SHEET 2015

2016 United Nations Political Declaration on Ending AIDS sets world on the Fast-Track to end the epidemic by 2030

This technical paper analyses investments by OECD Development Assistance Committee (DAC) donors in six

UNAIDS Technical Support Division of Labour. Summary & Rationale

Implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2010 Progress Report SPECIAL REPORT.

The health economic landscape of cancer in Europe

National Aids Spending Assessment Report

Eradicating Polio: Why and How? Dr Roland Sutter, World Health Organization 20 September 2011

CRS Report for Congress

TOBACCO CONTROL ECONOMICS TOBACCO FREE INITIATIVE PREVENTION OF NONCOMMUNICABLE DISEASES

Type 1 Diabetes Australian Research Impact Analysis

Survey of G7 Nations on HIV Spending in Developing Countries

Latest Funding Trends in AIDS Response

Case study examining the impact of German reunification on life expectancy

The road towards universal access

The Global Fund & UNICEF Partnership

HAS DONOR PRIORITIZATION OF HIV/AIDS CONTROL DISPLACED AID FOR OTHER HEALTH CAUSES?

Donor contributions and commitments as of April 2011

MAKING THE MONEY WORK. through greater UN support for AIDS responses. The Consolidated UN Technical Support Plan for AIDS

AIDS Funding Landscape in Asia and the Pacific

PROJECT INFORMATION DOCUMENT (PID) CONCEPT STAGE Report No.: AB4078 Project Name

10.4 Advocacy, Communication and Social Mobilization Working Group: summary strategic plan,

Renewing Momentum in the fight against HIV/AIDS

UNAIDS 99.1E (English original, March 1999) This document, presenting a speech given at the United Nations General Assembly Special Session on Drugs,

Good Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014

TRACKING FUNDING FOR MICROBICIDE RESEARCH & DEVELOPMENT:

CFS MYPoW Chair Proposal on the HLPE work in 2018

Resolution adopted by the General Assembly. [without reference to a Main Committee (A/62/L.39 and Add.1)]

U.S. Response to the Global Threat of HIV/AIDS: Basic Facts

MENTAL HEALTH DISORDERS: THE ECONOMIC CASE FOR ACTION Mark Pearson Head of Department, OECD Health Division

U.S. Funding for International Family Planning & Reproductive Health

NBER WORKING PAPER SERIES ALCOHOL CONSUMPTION AND TAX DIFFERENTIALS BETWEEN BEER, WINE AND SPIRITS. Working Paper No. 3200

Six things you need to know

2. Treatment coverage: 3. Quality of care: 1. Access to diagnostic services:

The road towards universal access

GLP in the European Union Ecolabel detergents, GLP and accreditation

26 th Meeting of the UNAIDS Programme Coordinating Board Geneva, Switzerland June 2010

Drug Consumption Rooms Worldwide

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

IARC A UNIQUE AGENCY. Cancer research for cancer prevention

2010 global TB trends, goals How DOTS happens at country level - an exercise New strategies to address impediments Local challenges

TRANSITIONING FROM DONOR SUPPORT FOR TB & HIV IN EUROPE

Assessment of G8 Commitments on Maternal, Newborn and Child Health

STRATEGIC APPROACH & WORKPLAN 2007

Making the Money Work AIDS Strategy and Action Plan (ASAP)

FAO of the UN, WHO and OIE with the collaboration of UNSIC and UNICEF. Background Paper

Working for an International Organization in Public-Private Partnership : The Global Fund to Fight AIDS, Tuberculosis and Malaria

Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )

Q Update Tracking the Effect of the Economic Crisis on Pharmaceutical Consumption, Expenditures

The Current Status of Cardiac Electrophysiology in ESC Member Countries J. Brugada, P. Vardas, C. Wolpert

Malawi Moves Ahead. The National HIV and AIDS Response From MDGs to SDGs. Presented by Mr. Davie Kalomba, Executive Director National AIDS Commission

Innovation, Access and Use Department of Essential Medicines and Health Products WHO

On 24 May 2005 the Council (GAERC), in its formation of Development Ministers, adopted the conclusions in Annex I.

The Economic and Social Council, Recalling the United Nations Millennium Declaration13 and the 2005 World Summit Outcome, 1

Role of the UN agencies in the Prevention and control of NCDs Dr Jacob Kumaresan Executive Director WHO office at the United Nations

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

Global Fund experience on financing the fight against AIDS, tuberculosis and malaria History and lessons learnt Hearings at WHO GCM/NCD working group

60TH SESSION OF THE UNITED NATIONS COMMISSION ON HUMAN RIGHTS

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

NATIONAL COST OF OBESITY SEMINAR. Dr. Bill Releford, D.P.M. Founder, Black Barbershop Health Outreach Program

Thomas Karlsson & Esa Österberg National Research and Development Centre for Welfare and Health Alcohol and Drug Research Group P.O.

An analysis of structural changes in the consumption patterns of beer, wine and spirits applying an alternative methodology

Botswana Advocacy paper on Resource Mobilisation for HIV and AIDS

Monitoring PEPFAR Program Expenditures

Transcription:

Financing the response to AIDS in low- and middleincome countries: International assistance from the G8, European Commission and other donor Governments in 2008 Authors: Jennifer Kates (Kaiser Family Foundation), Eric Lief (The Stimson Center), Carlos Avila (UNAIDS). July 2009

Introduction Financing a sufficient and sustained response to the HIV/AIDS epidemic in low- and middle- income countries has emerged as one of the world s greatest health and development challenges, and one that will be with us for the foreseeable future. International assistance from donor governments, through bilateral aid and contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund) and other financing channels such as UNITAID, the international drug purchase facility, is a critical part of this response. Other sources of funding include multilateral institutions, the private sector, and domestic spending by many affected-country governments and the households and individuals within them. Although funding from all these sources has risen significantly over the past decade, the difference between the UNAIDS estimate of resources needed compared to resources available in 2008 was approximately $6.5 billion. The current global economic crisis has raised concerns about the ability to fill this gap, most of which will need to be filled by the international community. Tracking funding by the international community, therefore, is critical. Each year, UNAIDS and the Kaiser Family Foundation collect and analyze data to document international assistance for AIDS in low- and middle- income countries. This latest report provides data from 2008, the most recent year available. As such, it represents funding levels reflecting budgets largely set in place before the acceleration of the current global economic crisis. The analysis is based on data provided by governments -- including the Group of Eight (G8), Australia, Ireland, The Netherlands, Norway, Sweden, and other donor government members of the Organisation for Economic Co-operation and Development (OECD) s Development Assistance Committee (DAC) -- as well as from the European Commission (EC). It includes bilateral assistance, contributions to the Global Fund and, for the first time, contributions made to UNITAID, the international drug purchase facility, an innovative financing mechanism used to purchase drugs to fight HIV/AIDS, TB, and malaria. Data were collected and analyzed as part of a collaborative effort between UNAIDS and the Kaiser Family Foundation, with research assistance provided by the Stimson Center. 1

Key Highlights In 2008, international AIDS assistance from the G8, EC, and other donor governments reached its highest level to date: Identified new commitments totalled US$8.7 billion, of which US$6.7 billion was through bilateral channels (including earmarked multilateral commitments) (see Chart 4). Funding for the Global Fund totalled US$2.8 billion, of which US$1.7 billion represents an adjusted AIDS share (see Chart 7). Funding for UNITAID, the international drug purchase facility, totalled $349 million, of which $265 million represents an adjusted AIDS share. Disbursements, which reflect actual resources made available in a given year and therefore provide a better measure of resource availability, totalled US$7.7 billion in 2008 (see Chart 4). Disbursements have risen significantly over the past several years: Between 2002 and 2008, disbursements increased by more than six-fold, including a 56 percent increase in the last period (see Chart 4). Increases in international AIDS assistance from donor governments have been driven by a subset of G8 Members and, notably, a few non-g8 Members: In 2008, the United States was the largest donor in the world, accounting for more than half (51.3%) of disbursements by governments. The United Kingdom accounted for the second largest share (12.6%), followed by the Netherlands (6.5%), France (6.4%) and Germany (6.2%). Norway and Sweden followed, at 2.0% respectively, each accounting for more than some G8 Members (see Chart 5). Most international assistance identified for purposes of this analysis is channelled bilaterally (or is earmarked through multilateral instruments, such as UNAIDS, and is therefore considered bilateral), accounting for 74% of disbursements in 2008; the remainder is provided through the Global Fund and UNITAID. Funding channel patterns vary significantly by donor (see Chart 8). Other international financing sources -- not documented in this report -- include multilateral institutions such as U.N. agencies, multilateral development banks such as the World Bank, and the private sector. 2

Key Highlights continued UNAIDS estimates that US$22.1 billion was needed to address the epidemic in low- and middle- income countries in 2008: Of this, an estimated US$15.6 billion was available from all sources (public and private), with bilateral international assistance accounting for 37% (US$5.7 billion in disbursements). The U.S., U.K., and the Netherlands accounted for the largest shares of such assistance funding. Still, there was a gap of US$6.5 billion between resources available from all sources and resources needed in 2008, as estimated by UNAIDS (see Chart 9). Assessing fair share in the context of international assistance is a challenging task and there is no single, agreed upon methodology for doing so. Two different methodologies used in this analysis indicate that, in 2008: The U.S. provided 22% of the funding available for AIDS from all sources (donor governments, multilaterals, the private sector, and domestic sources), the largest share of any donor and just below its share of the world s economy as measured by gross domestic product or GDP (24% in 2008). The U.K., the Netherlands, and Ireland each provided greater shares of total AIDS resources than their shares of GDP (see Chart 10). When standardized by GDP per US$1 million, to account for differences in the sizes of government economies, the Netherlands provided the highest amount of resources for AIDS in 2008, followed by the United Kingdom, Ireland, and the U.S., ranking fourth (see Chart 11). 3

International AIDS Assistance: Trends in G8/EC & Other Donor Government Assistance, 2002-2008 USD billions $8.7 $7.7 $3.6 $4.3 $5.6 $6.6 $2.8 $3.5 $3.9 $4.9 $1.6 $2.0 $1.2 $1.6 2002 2003 2004 2005 2006 2007 2008 2002 2003 2004 2005 2006 2007 2008 Commitments Disbursements Sources: UNAIDS and Kaiser Family Foundation analyses; Global Fund to Fight AIDS, Tuberculosis and Malaria online data queries; UNITAID Annual Report, 2008; OECD CRS online data queries; UNAIDS, PCB(13)/02.5, 28 November 2002; UNAIDS, PCB(14)/03 Conference Paper 2a, 25 June 2003. Notes: Bilateral funding includes HIV-earmarked multilateral funding but does not include the Global Fund or UNITAID. Global Fund contributions adjusted to represent estimated HIV share based on Global Fund grant distribution by disease to date (61% for HIV). UNITAID contributions adjusted to represent estimated HIV share based on distributions by disease to date (76% for HIV). Data from 2002 and 2003 do not include Global Fund contributions. See Methodology for additional detail. 4

International AIDS Assistance: G8/EC & Other Donor Governments as Share of Total Disbursements, 2008 USD billions Netherlands 6.5% France 6.4% United Kingdom 12.6% United States 51.3% Germany 6.2% Other Govts 4.0% Norway 2.0% Sweden 2.0% Canada 1.8% Japan 1.7% Italy 1.6% $7.7 billion Total Disbursements Ireland 1.5% EC 1.1% Australia 1.4% Sources: UNAIDS and Kaiser Family Foundation analysis June 2009; Global Fund to Fight AIDS, Tuberculosis and Malaria online data queries; UNITAID Annual Report, 2008; OECD CRS online data queries; UNAIDS, PCB(13)/02.5, 28 November 2002; UNAIDS, PCB(14)/03 Conference Paper 2a, 25 June 2003. Notes: Bilateral funding includes HIV-earmarked multilateral funding but does not include the Global Fund or UNITAID; Global Fund contributions adjusted to represent estimated HIV share based on Global Fund grant distribution by disease to date (61% for HIV). UNITAID contributions adjusted to represent estimated HIV share based on distributions by disease to date (76% for HIV). Data from 2002 and 2003 do not include Global Fund contributions. See Methodology for additional detail. 5

International AIDS Assistance: G8/EC & Other Donor Governments as Share of Bilateral Disbursements, 2008 USD billions Netherlands 7.5% Germany 5.0% Norway 1.8% Ireland 1.6% Other Govts 1.5% United Kingdom 15.6% Sweden 1.5% Australia 1.5% United States 60.5% Canada 1.0% France 1.2% Italy 0.2% Japan 0.4% EC 0.7% $5.7 billion Bilateral Disbursements Sources: UNAIDS and Kaiser Family Foundation analysis June 2009; OECD CRS online data query June 2009. Notes: Bilateral funding includes HIV-earmarked multilateral funding, but does not include the Global Fund or UNITAID. See Methodology for additional detail. 6

International AIDS Assistance: G8/EC & Other Donor Governments as Share of Global Fund Contributions for AIDS from DAC* Donor Governments, 2008 USD billions Germany 11.1% France 14.8% United States 28.6% Other Govts 10.4% Italy 6.6% Ireland 1.3% Japan 6.5% Australia 1.4% Canada 4.6% Netherlands 4.0% Sweden 3.7% United Kingdom 2.8% EC 2.4% Norway 1.9% $1.7 billion Sources: UNAIDS and Kaiser Family Foundation analysis, June 2009; Global Fund to Fight AIDS, Tuberculosis and Malaria online data query June 2009. Notes: Global Fund contributions adjusted to represent estimated HIV share based on Global Fund grant distribution by disease to date (61% for HIV). *Members of the OECD s Development Assistance Committee (DAC): www.oecd.org/dac. See Methodology for additional detail. 7

International AIDS Assistance: G8/EC Funding Channels for Disbursements, 2008 $7.7B $968.7m $3.951B $500.8m $112.5m $109.1m $155.3m $477.7m $151.2m $82.8m $137.6m $310.6m $133.1m $493.1m $122.7m 26% 8% 12% 14% 20% 22% 74% 92% 88% 86% 80% 78% 33% 40% 42% 49% 57% 71% 67% 60% 58% 51% 84% 86% 93% Global Fund / UNITAID Bilateral 43% 29% 16% 14% 7% All United Kingdom United States Netherlands Ireland Australia Norway Germany Sweden EC Canada Other Govts Japan France Sources: UNAIDS and Kaiser Family Foundation analysis June 2009; Global Fund to Fight AIDS, Tuberculosis and Malaria online data queries; UNITAID Annual Report, 2008; OECD CRS online data queries; UNAIDS, PCB(13)/02.5, 28 November 2002; UNAIDS, PCB(14)/03 Conference Paper 2a, 25 June 2003. Notes: Bilateral funding includes HIV-earmarked multilateral funding; Multilateral funding includes Global Fund contributions adjusted to represent estimated HIV share based on Global Fund grant distribution by disease to date (61% for HIV) and UNITAID contributions adjusted to represent estimated HIV share based on distributions by disease to date (76% for HIV). See Methodology for additional detail. Italy 8

Resources Available for AIDS from All Sources Compared to UNAIDS Estimate of Resources Needed, 2008 USD billions $6.5 $15.6b Available $9.9 $5.7 Gap All Other (Multilateral, Private, Domestic) Donor Governments (Bilateral) $22.1b Needed Total Global Resource Needs in Low & Middle Income Countries Sources: UNAIDS and Kaiser Family Foundation analysis June 2009; Global Fund to Fight AIDS, Tuberculosis and Malaria online data query June 2009; UNITAID Annual Report, 2008; OECD CRS online data query June 2009; UNAIDS, Resource Needs for an Expanded Response to AIDS in Low- and Middle Income Countries, 2006; UNAIDS, What Countries Need: Investments Needed for 2010 Targets, 2009; UNAIDS, Unified Budget and Workplan 2008-2009. Notes: Bilateral funding includes HIV-earmarked multilateral funding but does not include the Global Fund or UNITAID; Global Fund contributions adjusted to represent estimated HIV share based on Global Fund grant distribution by disease to date (61% for HIV). UNITAID contributions adjusted to represent estimated HIV share based on distributions by disease to date (76% for HIV). Other financing sources include multilateral, private, and domestic government funding. Resources available are estimated and represent disbursements from all sources. See Methodology for additional detail. 9

Assessing Fair Share 1: Donor Share of World GDP Compared to Donor Share of All Resources Available for AIDS, 2008 United States United Kingdom Netherlands Germany Norway Sweden Australia Ireland France Canada Japan Italy 4.4% 5.7% 1.4% 2.8% 6.0% 1.8% 0.8% 0.7% 0.8% 0.6% 1.7% 0.6% 0.5% 0.6% 4.7% 0.4% 2.5% 0.4% 8.1% 0.1% 3.8% 0.1% 23.5% 22.2% Share of World GDP Share of All Resources for HIV/AIDS Sources: UNAIDS and Kaiser Family Foundation analysis June 2009; International Monetary Fund, World Economic Outlook Database, April 2009. Notes: Calculations based on bilateral disbursements only, and include HIV-earmarked multilateral funding, but do not include the Global Fund or UNITAID. Resources available are estimated and represent disbursements from all sources. See Methodology for additional detail. 10

Assessing Fair Share 2: Donor Rank by Disbursements for AIDS per US$1 Million GDP*, 2008 Netherlands $496.1 United Kingdom Ireland United States Norway Sweden $332.9 $328.5 $242.5 $226.4 $180.2 Australia Germany Canada France Japan Italy $84.4 $78.3 $38.9 $23.3 $4.3 $3.8 Sources: UNAIDS and Kaiser Family Foundation analysis June 2009; International Monetary Fund, World Economic Outlook Database, April 2009. Notes: Calculations based on bilateral disbursements only, and include HIV-earmarked multilateral funding, but do not include the Global Fund or UNITAID. GDP = gross domestic product. See Methodology for additional detail. 11

International AIDS Assistance: G8/EC & Other Donor Governments, Summary Data Table, 2008 USD millions Bilateral Global Fund Global Fund UNITAID UNITAID Total (100%) Adjusted (61%) G8 Members in Bold. G8 share is 87% of total commitments and 86% of total disbursements. Total (100%) Adjusted (76%) Commitment Disbursement Government Commitment Disbursement Australia $ 85.3 $ 85.3 $ 38.9 $ 23.7 $ 109.1 $ 109.1 Canada $ 58.8 $ 58.8 $ 129.1 $ 78.8 $ 137.6 $ 137.6 France $ 66.8 $ 66.8 $ 416.8 $ 254.2 $ 226.5 $ 172.1 $ 493.1 $ 493.1 Germany $ 287.2 $ 287.2 $ 312.2 $ 190.4 $ 477.7 $ 477.7 Ireland $ 89.8 $ 89.8 $ 37.2 $ 22.7 $ 112.5 $ 112.5 Italy $ 20.3 $ 8.7 $ 186.9 $ 114.0 $ 134.3 $ 122.7 Japan $ 21.0 $ 21.0 $ 183.8 $ 112.1 $ 133.1 $ 133.1 Netherlands $ 431.1 $ 431.1 $ 114.2 $ 69.7 $ 500.8 $ 500.8 Norway $ 103.3 $ 103.3 $ 52.6 $ 32.1 $ 26.2 $ 19.9 $ 155.3 $ 155.3 Sweden $ 87.3 $ 87.3 $ 104.8 $ 63.9 $ 151.2 $ 151.2 United Kingdom $ 890.1 $ 890.1 $ 79.5 $ 48.5 $ 39.6 $ 30.1 $ 968.7 $ 968.7 United States $ 4,411.1 $ 3,458.5 $ 808.1 $ 492.9 $ 4,904.0 $ 3,951.4 European Commiss $ 54.8 $ 42.1 $ 66.7 $ 40.7 $ 95.5 $ 82.8 Other Governments $ 131.6 $ 88.6 $ 293.2 $ 178.9 $ 56.8 $ 43.2 $ 353.6 $ 310.6 TOTAL $ 6,738.5 $ 5,718.6 $ 2,824.0 $ 1,722.6 $ 349.1 $ 265.3 $ 8,726.5 $ 7,706.6 Total Sources: UNAIDS and Kaiser Family Foundation analysis June 2009; Global Fund to Fight AIDS, Tuberculosis and Malaria online data query June 2009; OECD CRS online data query June 2009. Notes: Bilateral funding includes HIV-earmarked multilateral funding but does not include the Global Fund or UNITAID. Global Fund contributions adjusted to represent estimated HIV share based on Global Fund grant distribution by disease to date (61% for HIV). UNITAID contributions adjusted to represent estimated HIV share based on distributions by disease to date (76% for HIV). U.S. bilateral commitment data correspond to obligations reported for the 2008 fiscal year (and therefore may differ somewhat from amounts appropriated by Congress in that year). U.S. Global Fund contributions correspond to amounts received by the Fund during the 2008 calendar year, regardless of which U.S. fiscal year such disbursements pertain to. U.K. and Canadian data are preliminary estimates. With the exception of the U.S., Italy, and the EC, disbursements used as proxy for commitments. Netherlands disbursement data differ from HGIS annual reports, due to exclusion of TB and malaria funding, imputed multilateral funding, and indirect administrative costs. "Other government" totals represent 2007 data reported to the OECD and by the Global Fund and UNITAID. Japan data represents final 2008 disbursements. See Methodology for additional detail. 12

Annex: Methodology This project represents a collaboration between the Joint United Nations Programme on AIDS (UNAIDS) and the Kaiser Family Foundation. Data provided in this report were collected and analyzed by UNAIDS and the Kaiser Family Foundation. The Stimson Center conducted research for this project. Bilateral and multilateral data on donor government assistance for AIDS in low- and middle-income countries were collected from multiple sources. The research team solicited bilateral assistance data directly, using uniform protocols, from the governments of Australia, Canada, France, Germany, Ireland, Japan, The Netherlands, Norway, Sweden, The United Kingdom, The United States, and The European Commission during the first half of 2009, representing the fiscal year 2008 period. Direct data collection from these donors was desirable because the latest official statistics on international AIDS specific assistance from the Organisation for Economic Co-operation and Development (OECD) Creditor Reporting System (CRS) (see: http://www.oecd.org/dataoecd/20/29/31753872.htm) are from 2007 and do not include all forms of international assistance (e.g., the CRS no longer collects data on aid to countries and territories in transition, such as those in Central and Eastern Europe and the Newly Independent States of the former Soviet Union). In addition, the CRS data may not include certain funding streams provided by donors, such as mixed grants to non-governmental organizations. The research team therefore undertook direct data collection from the donors who provide significant shares for international AIDS assistance through bilateral channels. Where donor governments were members of the European Union (EU), the research team ensured that no double-counting of funds occurred between EU Member reported amounts and EC reported amounts for international AIDS assistance. Figures obtained directly using this approach should be considered as the upper bound estimation of financial flows in support of HIV-related activities. Although the Russian Federation is a Member of the G8 and made significant contributions to the Global Fund in 2008, it was a net recipient of HIV/AIDS assistance, and therefore is not included in the donor analysis. 13

Methodology continued Data for all other governments Austria, Belgium, Denmark, Finland, Greece, Luxembourg, New Zealand, Portugal, Spain, Switzerland were obtained from the OECD CRS and are from calendar year 2007; these data, therefore, do not necessarily reflect 2008 calendar year amounts. However, collectively, these governments have accounted for less than 5 percent of bilateral commitments and disbursements in each of the past several years. Data included in this report represent funding assistance for HIV prevention, care, treatment and support activities, but do not include funding for international HIV research (which is not considered in estimates of resource needs for service delivery of HIV-related activities). Bilateral funding is defined as any earmarked (HIV/AIDS-designated) amount, including earmarked contributions to multilateral organizations, such as UNAIDS. In some cases, donors use policy markers to attribute portions of mixed-purpose projects to HIV/AIDS. This was done by the European Commission, the Netherlands, and the UK. U.S. bilateral commitment data correspond to amounts obligated during the 2008 fiscal year, and may therefore differ somewhat from the amounts appropriated in that same fiscal year. Global Fund contributions from the U.S. correspond to amounts received by the Fund during the 2008 calendar year, regardless of which U.S. fiscal year such disbursements pertain to. Data from the U.K., Norway, Canada, the European Commission and Japan should be considered preliminary estimates. With the exceptions of the U.S., Italy, and the European Commission, disbursements were used as a proxy for commitments. Netherlands disbursement data differ from HGIS annual reports, due to exclusion of TB and malaria funding, imputed multilateral funding, and indirect administrative costs. 14

Methodology continued Included in multilateral funding were contributions to the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) (see: http://www.theglobalfund.org/en/), and UNITAID (see: http://www.unitaid.eu/). All Global Fund contributions were adjusted to represent 61% of the donor s total contribution, reflecting the Fund s reported grant approvals for HIV-related projects to date. UNITAID contributions were adjusted to represent 76% of the donor s total contribution, reflecting UNITAID s reported funding by disease during the 2008 calendar year. Other than contributions provided by governments to the Global Fund and UNITAID, un-earmarked general contributions to United Nations entities, most of which are membership contributions set by treaty or other formal agreement (e.g., the World Bank s International Development Association or United Nations country membership assessments), are not identified as part of a donor government s AIDS assistance even if the multilateral organization in turn directs some of these funds to AIDS. Rather, these would be considered as AIDS funding provided by the multilateral organization, as in the case of the World Bank s efforts, and are not considered for purposes of this report. Bilateral assistance data were collected for disbursements. A disbursement is the actual release of funds to, or the purchase of goods or services for, a recipient. Disbursements in any given year may include disbursements of funds committed in prior years and in some cases, not all funds committed during a government fiscal year are disbursed in that year. In addition, a disbursement by a government does not necessarily mean that the funds were provided to a country or other intended end-user. Commitments, or obligations, represent firm decisions that funding will be provided, regardless of the time at which actual outlays, or disbursements, occur. In recent years, most governments have ceased use of commitment accounting other than for administrative purposes, have converted to cash accounting frameworks, and accordingly did not provide commitment data for purposes of this report; in such cases, disbursements were used a proxy for commitments. In the U.S. case, both disbursement and commitment data were available for analysis. 15

Methodology continued Data collected directly from donor governments reflect the fiscal year (FY) period as defined by the donor which varies by country. The U.S. fiscal year runs from October 1-September 30. The Australian fiscal year runs from July 1-June 30. The fiscal years for Canada, Japan, and the U.K. are April 1-March 31. The EC, France, Germany, Italy, Ireland, the Netherlands, Norway and Sweden use the calendar year. The OECD uses the calendar year, so data collected from the CRS for other donor governments reflect January 1- December 31. Among the key multilateral institutions analyzed, the World Bank fiscal year is July 1-June 30. Most UN agencies use the calendar year and their budgets are biennial. The Global Fund s fiscal year is also the calendar year. In some cases, therefore, data obtained directly from donors on their fiscal year 2008 contributions to the Global Fund may differ from amounts reported on the Global Fund s website, which are by calendar year. All data are expressed in US dollars (USD). Where data were provided by governments in their currencies, they were adjusted by average daily exchange rates to obtain a USD equivalent, based on foreign exchange rate historical data for 2008, available from the U.S. Federal Reserve (see: http://www.federalreserve.gov/). Data obtained from the Global Fund were already adjusted by the Global Fund to represent a USD equivalent. Data on gross domestic product (GDP) were obtained from the International Monetary Fund s World Economic Outlook Database and represent current price data for 2008 (see: http://www.imf.org/external/pubs/ft/weo/2009/01/weodata/index.aspx). 16

UNAIDS is an innovative joint venture of the United Nations, bringing together the efforts and resources of the UNAIDS Secretariat and ten UN system organizations in the AIDS response. The Secretariat headquarters is in Geneva, Switzerland with staff on the ground in more than 80 countries. The Cosponsors include UNHCR, UNICEF, WFP, UNDP, UNFPA, UNODC, ILO, UNESCO, WHO and the World Bank. Contributing to achieving global commitments to universal access to comprehensive interventions for HIV prevention, treatment, care and support is the number one priority for UNAIDS. Visit the UNAIDS Web site at www.unaids.org The Kaiser Family Foundation is a non-profit private operating foundation, based in Menlo Park, California, dedicated to producing and communicating the best possible analysis and information on health issues at www.kff.org This publication (#7347-05) is available on the Kaiser Family Foundation s website at www.kff.org and at the UNAIDS website at www.unaids.org. 17